Facts
- Product: Immunotherapy against cancer
- Sector: Life Sciences & Health
- Founded: 2013
- Amount invested: € 300,000
- Status: Active
Helping the body destroy tumours
In many cases, patients with cancer have a suppressed immune system. As a result, harmful foreign bodies are not recognised as tumour cells and are not destroyed. Hercules Pharmaceuticals is working on a drug that will enable the body to reduce the growth and spread of various forms of cancer more effectively. The drug inhibits the aryl hydrocarbon receptor in the body, which has a high expression in a number of cancers and suppresses a cancer patient’s immune system.